VTRS · 10-Q · 2026Q2 · Full report

Revenue Performance and Mix

Viatris Inc · 2026-08-06 · Importance 59 · Surprise 32 · From source text

Second-quarter 2026 total revenues increased 5% year over year to $3.76 billion from $3.58 billion, while constant-currency revenues rose 4% to $3.71 billion. Greater China net sales increased 21% to $713.8 million, or 16% on a constant-currency basis, driven by e-commerce, retail and increased marketing and selling efforts. Developed Markets net sales increased 4% to $2.19 billion, supported by octreotide acetate in North America and estradiol transdermal systems, while Europe faced supply constraints. For the six months ended June 30, 2026, total revenues rose 6% to $7.27 billion, with constant-currency net sales growth of 3% driven by $171.8 million of new product sales and $60.7 million of net base-business growth; the top ten products represented 39% of net sales versus 37% in the prior-year period.

Key facts

• Combined summarized revenues and gross profit were $— and $— respectively for the six months ended June 30, 2026 and for the year ended December 31, 2025; loss from operations was $(591.7) for the six months ended June 30, 2026 and $(1,008.2) for the year ended December 31, 2025; net earnings (loss) were $57.6 for the six months ended June 30, 2026 and $(3,514.9) for the year ended December 31, 2025. source
• Greater China net sales were $713.8 million for the three months ended June 30, 2026, an increase of $124.9 million or 21%, with a favorable foreign currency impact of approximately $28.6 million and constant currency net sales growth of approximately $96.3 million or 16%. source
• Adjusted net earnings and adjusted EPS for the three months ended June 30, 2026 were $808.5 and $0.69, respectively, and for the three months ended June 30, 2025 were $726.0 and $0.62, respectively. source
• Adjusted net earnings and adjusted EPS for the six months ended June 30, 2026 were $1,502.6 and $1.28, respectively, and for the six months ended June 30, 2025 were $1,326.3 and $1.11, respectively. source
• Developed Markets net sales were $2,193.7 million for the three months ended June 30, 2026 compared to $2,119.3 million for the prior year period, an increase of $74.4 million or 4%, and North America net sales totaled approximately $882.7 million while Europe net sales totaled approximately $1.31 billion. source
• On a constant currency basis, net sales for the six months ended June 30, 2026 increased by approximately $232.5 million, or 3%, compared to the prior year period, driven by new product sales primarily in Developed Markets of approximately $171.8 million and net base business growth of approximately $60.7 million driven by Greater China. source
• Total revenues for the three months ended June 30, 2026 were $3,756.8 million, compared to $3,582.1 million for the three months ended June 30, 2025, an increase of $174.7 million or 5%. source
• Total revenues for the six months ended June 30, 2026 were $7,273.8 million, compared to $6,836.4 million for the six months ended June 30, 2025, an increase of $437.4 million or 6%. source

Impact estimates